Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Fluconazole impurity standardBP

Fluconazole impurity standardBP

NA

DISCOVER
Fosfomycin Impurity A

Fosfomycin Impurity A

132125-60-1

DISCOVER
Flutamide

Flutamide

13311-84-7

DISCOVER
Flurazepam

Flurazepam

17617-23-1

DISCOVER
Fondenafil

Fondenafil

944241-52-5

DISCOVER
Fluvastatin Sodium

Fluvastatin Sodium

93957-55-2

DISCOVER
Fusidic acid sodium salt

Fusidic acid sodium salt

751-94-0

DISCOVER
Fenbendazole-amine HCl

Fenbendazole-amine HCl

1448346-29-9

DISCOVER
Fluocinolone acetonide

Fluocinolone acetonide

67-73-2

DISCOVER
Gabapentin Related compound A/ 4,4-Pentamethylene-2-pyrrolidone

Gabapentin Related compound A/ 4,4-Pentamethylene-2-pyrrolidone

64744-50-9

DISCOVER
Gabapentin USP

Gabapentin USP

60142-96-3

DISCOVER
Guanine USP

Guanine USP

73-40-5

DISCOVER